May 2009

UMMS researchers isolate first ‘neuroprotective’ gene in patients with amyotrophic lateral sclerosis

Some more good research news. I wouldn’t mind getting a dose of this gene. Because survival with ALS is normally only three to five years, patients with the KIFAP3 gene variant experience a substantial improvement. In fact, the impact of this genetic variant is comparable to the effect of the only drug (Riluzole) now approved [...]

Read the full article →

Power Wheel Chair

This past Wednesday I received my power wheel chair. All I can say is that it has allowed me to places where I couldn’t go before! Like now I can go for an evening stroll and enjoy the weather. I can now race with my daughter, it’s kind of unmatched because she is on her [...]

Read the full article →

My Office

So this past week I worked from my home office. Working from home was good and didn’t had much problems with keeping in touch with my team. Here are some pictures of my new office.

Read the full article →

PharmaLive: Trophos initiates pivotal efficacy study of olesoxime in Amyotrophic Lateral Sclerosis (Lou Gehrig’s disease)

Another new drug for helping patients with ALS. Olesoxime (TRO19622) is the lead compound of the Trophos’ proprietary cholesterol-oxime compound family of mitochondrial pore modulators. Preclinical studies have demonstrated that the compounds promote the function and survival of neurons and other cell types under disease-relevant stress conditions through interactions with the mitochondrial permeability transition pore [...]

Read the full article →

Summer is here!

It’s May and days are getting warmer. It feels nice to have warm days after such a cold winter. Starting Monday I am going to work from home. This is a great help for me, because now I can just go to work not worrying about getting ready or about walking down the hallways. I [...]

Read the full article →